Targeting the endocannabinoid system in the treatment of fragile X syndrome.
Busquets-Garcia A, Gomis-González M, Guegan T, Agustín-Pavón C, Pastor A, Mato S, Pérez-Samartín A, Matute C, de la Torre R, Dierssen M, Maldonado R, Ozaita A.
Busquets-Garcia A, et al. Among authors: maldonado r.
Nat Med. 2013 May;19(5):603-7. doi: 10.1038/nm.3127. Epub 2013 Mar 31.
Nat Med. 2013.
PMID: 23542787